{"id":"W2965677886","doi":"10.1200/jco.2006.24.18_suppl.7161","title":"Identifying patients with non-small cell lung cancer (NSCLC) unlikely to benefit from erlotinib: An exploratory analysis of National Cancer of Institute of Canada Clinical Trials Group BR.21","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Erlotinib; Internal medicine; Lung cancer; Oncology; Proportional hazards model; Anemia; Weight loss; Erlotinib Hydrochloride; Placebo; Cancer; Clinical trial; Post-hoc analysis; Performance status; Epidermal growth factor receptor; Obesity; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007443735,0.0007981046,0.001537933,0.00054291,0.0007083066,0.0008504105,0.0008389857,0.0006473372,0.001488066],"category_scores_gemma":[0.009572455,0.0002863431,0.002311506,0.0007042325,0.0004149477,0.0003926318,0.0006976294,0.0008507076,0.0002020098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001287451,"about_ca_system_score_gemma":0.004250958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01124101,"about_ca_topic_score_gemma":0.0354439,"domain_scores_codex":[0.9954797,0.003055683,0.0002241408,0.0004184823,0.0004963547,0.0003255176],"domain_scores_gemma":[0.9931103,0.004129733,0.0009576453,0.0005664545,0.0005433827,0.0006924981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1429261,0.002207219,0.7976317,0.0006335764,0.007588611,0.0006846422,0.0005374245,0.004859588,0.003133919,0.0004633481,0.003943988,0.03538981],"study_design_scores_gemma":[0.01258938,0.01299126,0.9557867,0.00005579782,0.003334075,0.0006220279,0.0002819993,0.01056405,0.0005289937,0.0004471936,0.002737111,0.00006148029],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958082,0.0007031668,0.0004668988,0.0002407746,0.00000799087,0.0005590605,0.00161635,0.00001032697,0.0005872215],"genre_scores_gemma":[0.9940811,0.0001230771,0.0009149208,0.0002043162,0.00002507545,0.0004080998,0.003828547,0.000007308084,0.000407481],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01124101,"threshold_uncertainty_score":0.03936672,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1325686615494445,"score_gpt":0.4964888718721104,"score_spread":0.3639202103226659,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}